跳至主要内容
临床试验/EUCTR2017-003084-34-GB
EUCTR2017-003084-34-GB进行中(未招募)1 期

The pharmacological effects of granulocyte-colony stimulating factor (GCSF) on frataxin expression in patients with Friedreich Ataxia - GCSF for Friedreich Ataxia

niversity of Bristol0 个研究点目标入组 7 人开始时间: 2017年11月28日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Genetic diagnosis of FRDA
  • Age of over 18 and under 60
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 7
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Pregnancy, breastfeeding or lactation
  • Significant abnormalities on baseline bloods (full blood count, renal and liver function)
  • Previous diagnosis of haematological disorder (including malignancy)
  • Previous history of splenomegaly
  • Previous history of autoimmune disease
  • Previous history of pulmonary infiltrates, pulmonary fibrosis or haemoptysis

研究者

发起方
niversity of Bristol

相似试验